Chinese Japanese Germany Korea


Anti-infection drug Chemical Properties Uses Production method Category Toxicity grading Acute toxicity Flammability and hazardous characteristics Storage Characteristics Extinguishing agent
Norfloxacin structure
Chemical Name:
Molecular Formula:
Formula Weight:
MOL File:

Norfloxacin Properties

Melting point:
1.2504 (estimate)
storage temp. 
Very slightly soluble in water, slightly soluble in acetone and in ethanol (96 per cent).
Crystalline Powder
pKa1 6.34; pKa2 8.75(at 25℃)
White to yellow
Water Solubility 
Soluble in acetic acid. Also soluble in acetone or cloroform. Slightly soluble in water
CAS DataBase Reference
70458-96-7(CAS DataBase Reference)


Hazard Codes  Xn
Risk Statements  20/21/22-36/37/38
Safety Statements  26-37/39-24/25
WGK Germany  2
RTECS  VB2005000
HazardClass  IRRITANT
HS Code  29335990
Toxicity LD50 in mice, rats (mg/kg): >4000 orally (both species); 1500 s.c. (both species); 470, >500 i.m.; 220, 270 i.v. (Irikura)

Norfloxacin price More Price(17)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich 33899 Norfloxacin VETRANAL 70458-96-7 100mg-r $105 2018-11-20 Buy
Sigma-Aldrich 1471506 Norfloxacin United States Pharmacopeia (USP) Reference Standard 70458-96-7 200mg $352.8 2018-11-20 Buy
TCI Chemical N0817 Norfloxacin >98.0%(HPLC)(T) 70458-96-7 5g $45 2018-11-22 Buy
TCI Chemical N0817 Norfloxacin >98.0%(HPLC)(T) 70458-96-7 25g $132 2018-11-22 Buy
Alfa Aesar J62652 Norfloxacin 70458-96-7 5g $47.2 2018-11-13 Buy

Norfloxacin Chemical Properties,Uses,Production

Anti-infection drug

Norfloxacin is a quinolone-class anti-infective drug with high degree of antibacterial activity against Escherichia coli, Shigella, Salmonella, Proteus, Pseudomonas aeruginosa and other gram-negative bacteria as well as excellent antibacterial effect against Staphylococcus aureus, pneumococcus bacteria and other Gram-positive bacteria. Its major site of action is in the bacterial DNA gyrase, causing the rapid cracking of the bacteria DNA helix and rapidly inhibiting the bacterial growth and reproduction, finally killing the bacteria. Moreover, it has a strong penetration capability into the cell walls so that it has a stronger bactericidal effect with a small stimulation on the gastric mucosa.
It is clinically used for treating the susceptible strains caused infection diseases in urinary tract, intestinal, ENT, gynecology, surgery and dermatology with the major indications as follows:
1, genitourinary infections: simple and complicated urinary tract infections, bacterial prostatitis, gonococcal urinary tract infections and reproductive tract infections.
2, gastrointestinal tract infections.
3, typhoid and other Salmonella infections.
Norfloxacin is a concentration-dependent drug which means that the in vivo concentration of the drug is directly proportional to the in vivo efficacy of the drug. The higher the concentration is, the better effect is. As the food will slow down the absorption rate of norfloxacin in the human body, the plasma concentration in the case of taking it before meals (with empty stomach) is 2-3 fold of that in the case of taking it after a meal; therefore, taking it after the meal will greatly reduce the efficacy and may also lead to the drug resistance issue of the susceptible bacteria to the norfloxacin and other similar antimicrobial drugs.
The above information is edited by the Chemicalbook of Dai Xiongfeng.

Chemical Properties

It is white to light yellow crystalline powder. It is odorless with slightly bitter taste. Upon exposure to the air, it can easily absorb moisture to form a hemihydrate. Its color will be deepened upon light. Solubility (mg/m1) in 25 ℃: 0.28 in water, 0.98 in methanol, 1.9 in ethanol, 5.1 in acetone, 5.5 in chloroform, 0.01 in diethyl ether, 0.15 in benzene, 0.94 in ethyl acetate, 5.1 in octanol, and 340 in glacial acetic acid. It is easily soluble in acidic or alkaline solution and slightly soluble in dimethylformamide. Its solubility in the water depends on the pH value and increases rapidly within the range of at pH <5 or pH> 10. It has a melting point of 218-224 ℃. It has also been reported of a melting point of 220-221 ℃. The maximum UV absorption (0.1mol/L sodium hydroxide solution): about 274,325.336nm (A has a height of about 1109, 437, 425). pKal 6.34; pKa2 8.75. Acute toxicity LD50 in mice, rats (mg/kg): All> 4000 oral administration; all hypodermic 1500; 470,> 500 intramuscular injection; 220,270 intravenous injection.


Norfloxacin belongs to third-generation quinolone antibacterial agent developed by Japanese Kyorin Company in 1978. It has features of broad antibacterial spectrum and strong antibacterial activity. It has a strong antibacterial effect against Escherichia coli, pneumobacillus, Aerobacter aerogenes, and Aerobacter cloacae, Proteus, Salmonella, Shigella, Citrobacter and Serratia. It is clinically used for treating the susceptible strain’s causing infections of urinary system, intestinal, respiratory system, surgery, gynecology, ENT and dermatology. It can also be used for the treatment of gonorrhea.

Production method

Nitration of o-dichlorobenzene or the chlorination of nitro chlorobenzene can both generate 3, 4-dichloro-nitrobenzene. It then undergoes reflux with potassium fluoride in dimethyl sulfoxide for being fluorinated to give 3-chloro-4-fluoro-nitrobenzene. In the presence of hydrochloric acid or aqueous acetic acid, it is further reduced by iron to 3-chloro-4-fluoro-aniline. 3-chloro-4-fluoro-aniline was then subject to reflux together with triethyl orthoformate and diethyl malonate (generate diethyl ethoxymethylenemalonate) in the presence of ammonium nitrate to give the condensation product with heating and cyclization in diphenyl ether or liquid paraffin to form the 7-chloro-6-fluoro-4-hydroxyquinoline-3-carboxylate with ethylation and further hydrolyzation to obtain the ethylated product. Finally, the ethylated product is condensed with piperazine to obtain norfloxacin. Its technology is relatively mature with a relative high yield being generally 40% to 65%. However, when introducing the piperazinyl group to the 7 position, the byproduct with the fluorine atom in 6 position can account for about 25%. It is hard for separation that can affect the yield. The overall yield calculated based on nitro chlorobenzene is above 8%.
Before the introduction of the pyrazine ring, 1-ethyl-6-fluoro-7-chloro-1,4-dihydro-4-oxo-quinoline-8-carboxylic acid ethyl ester should first react with fluoroboric acid or a boron trifluoride-diethyl ether or boron acetate to have the carbonyl group in 4 position form boron chelate. Further re-introduction of pyrazinyl can reduce the side reactions of the displacement of the position 7’s fluorine and can increase the yield by 15%, as well as improve the quality of the product.
There are many studies regarding the synthesis of norfloxacin at home and abroad. But there have not been too many way for being used in industrial production. The improvement of its synthesis route can be mainly reflected in two aspects. First, improve the process of forming a ring; the second is doing sth on the introduction of piperazine group.


toxic substances

Toxicity grading


Acute toxicity

intravenous-rat LD50: 245 mg/kg; Oral-Mouse LD50: 4000 mg/kg

Flammability and hazardous characteristics

it is combustible with combustion produces toxic fumes of nitrogen oxides and fluorides; Side effect when patients take it: musculoskeletal functional changes

Storage Characteristics

ventilation low-temperature and dry

Extinguishing agent

Dry powder, foam, sand, carbon dioxide, water spray


Norfloxacin is the first of the third generation nalidixic acid analogs to reach the marketplace. It exhibits potent in vitro and in vivo activity against Pseudomonas, enteric gram-negative rods and gram-positive cocci. Norfloxacin is orally effective in the treatment of urinary tract infections, including those due to organisms refractory to many other agents.

Chemical Properties

Off-white to light yellow cryst powder


Kyorin (Japan)


An antibacterial. Fluorinated quinolone antibacterial


Pefloxacin derivative as antibacterial. Fluorinated quinolone antibacterial.


ChEBI: A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enz me called DNA gyrase.

brand name

Chibroxin (Merck); Noroxin (Merck).

Antimicrobial activity

It is active against a wide range of Gram-negative bacteria, including Enterobacteriaceae and Campylobacter spp. Ps. aeruginosa, Acinetobacter, Serratia and Providencia spp. are weakly susceptible (and often resistant). It has no useful activity against anaerobes, Chlamydia, Mycoplasma and Mycobacterium spp.

Pharmaceutical Applications

A 6-fluoro, 7-piperazinyl quinoline available for oral administration and as an ophthalmic ointment.


Oral absorption: 50–70%
Cmax 400 mg oral :1.5 mg/L after 1–1.5 h
Plasma half-life :3–4 h
Volume of distribution: 2.5–3.1 L/kg
Plasma protein binding: 15%
absorption and distribution
Norfloxacin displays linear kinetics. There is no significant accumulation with the recommended dosage of 400 mg every 12 h. Food slightly delays but does not otherwise impair absorption. Antacids reduce absorption. It is widely distributed, but concentrations in tissues other than those of the urinary tract are low: levels in the prostate are around 2.5 mg/g.
Metabolism and excretion
Six or more inactive metabolites are produced. Around 30% of a dose appears as unchanged drug in the urine and <10% as metabolites, producing peak concentrations of microbiologically active drug of around 100–400 mg/L. Urinary recovery is halved by probenecid, with little effect on the plasma concentration. The apparent plasma elimination half-life increases with renal impairment, rising to around 8 h in the anuric patient. Some of the drug appears in the bile where concentrations three- to seven-fold greater than the simultaneous plasma levels are achieved, but this is not a significant route of elimination and hepatic impairment is without effect. Very variable quantities, averaging 30% of a dose, appear in the feces, producing concentrations of active agent of around 200–2000 mg/kg.

Clinical Use

Complicated and uncomplicated urinary tract infections (including prophylaxis in recurrent infections), prostatitis
Uncomplicated gonorrhea
Gastroenteritis caused by Salmonella, Shigella and Campylobacter spp., Vibrio cholerae
Conjunctivitis (ophthalmic preparation)

Side effects

Untoward reactions are those common to the fluoroquinolones. Gastrointestinal tract disturbances, which are generally mild, have been reported in 2–4% of patients. CNS disturbances have largely been limited to headache, drowsiness and dizziness. Co-administration with theophylline results in increased plasma theophylline levels.

Norfloxacin Preparation Products And Raw materials

Raw materials

Preparation Products

Norfloxacin Suppliers

Global( 346)Suppliers
Supplier Tel Fax Email Country ProdList Advantage
Shenzhen Sendi Biotechnology Co.Ltd.
0755-23311925 18102838259
0755-23311925 CHINA 3203 55
Henan DaKen Chemical CO.,LTD.
+86-371-55531817 CHINA 21909 58
Henan Tianfu Chemical Co.,Ltd.
0371-55170693 CHINA 20680 55
Mainchem Co., Ltd.
+86-0592-6210733 CHINA 32457 55
020-81716319 CHINA 2543 55
Hubei XinRunde Chemical Co., Ltd.
+8615102730682; +8618874586545
02783214688 CHINA 541 55
Xiamen AmoyChem Co., Ltd
+86 (0)592-605 1114 CHINA 6374 58
career henan chemical co
+86-371-86658258 CHINA 20653 58
Chemwill Asia Co.,Ltd.
86-21-51861608;;; CHINA 23982 58
Hubei Jusheng Technology Co.,Ltd.
86-188-71490254 CHINA 20094 58

View Lastest Price from Norfloxacin manufacturers

Image Release date Product Price Min. Order Purity Supply Ability Manufacturer
2019-04-12 Norfloxacin
US $1.00 / KG 1KG 99% 500kg Hebei Jimi Trading Co., Ltd.
2018-12-17 Norfloxacin
US $7.00 / kg 1kg 99% 100KG career henan chemical co
2018-03-15 Norfloxacin
US $10.00 / KG 10UG 99% 10MT Hubei XinRunde Chemical Co., Ltd.

70458-96-7(Norfloxacin)Related Search:

  • 1,4-dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylica
  • 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylica
  • am-715
  • MK-366
  • noroxin
  • norphloxacine
  • n-desmethylpefloxacin
  • chibroxin
  • floxacin 400
  • baccidal
  • AKOS NCG-0042
  • NorfloxacinUsp2699%Min
  • Barazan
  • N-Demethylpefloxacin
  • Norxacin
  • Sebercim
  • Norfloxacin(Norxacin)
  • Norfloxacin COS
  • Norfloxacin, 98%, analytical standard
  • Norfloxacin Standards
  • Norfloxacin for peak identification
  • 1-ethyl-6-fluoro-4-keto-7-piperazin-1-yl-quinoline-3-carboxylic acid
  • 1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid
  • 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid
  • 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid
  • BCBcMAP01_000218
  • BSPBio_002107
  • D00210
  • KBio2_004065
  • MLS000069650
  • NINDS_000084
  • Norflo
  • Norfloxacin (JP15/USP/INN)
  • Noroxin (TN
  • Prestwick1_000221
  • Prestwick3_000221
  • SMR000058200
  • SPBio_002182
  • norfloxaci
  • Zoroxin
  • Norfloxacin (base and/or unspecified salts)
  • 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-piperazino-3-quinolinecarboxylic acid, 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid
  • 1-Ethvl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid
  • Chibroxol
  • Floxacin
  • Fulgram
Copyright 2017 © ChemicalBook. All rights reserved